Oculis Holding AG (OCS) EPS (Basic) (2022 - 2026)
Quarterly EPS (Basic) rose 21.68% to -$0.05 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$30.1 through Mar 2026, up 36.17% year-over-year, with the annual reading at -$0.17 for FY2025, 12.34% up from the prior year.
Oculis Holding AG's EPS (Basic) history spans 5 years, with the latest figure at -$0.05 for Q1 2026.
- EPS (Basic) came in at -$0.05 for Q1 2026, down from $0.1 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.1 in Q4 2025 to a low of -$46.98 in Q3 2024.
- The 5-year median for EPS (Basic) is -$0.05 (2024), against an average of -$6.16.
- Year-over-year, EPS (Basic) crashed 97345.86% in 2024 and then surged 251.58% in 2025.
- Oculis Holding AG's EPS (Basic) stood at -$2.36 in 2022, then surged by 85.55% to -$0.34 in 2023, then surged by 80.89% to -$0.07 in 2024, then soared by 251.58% to $0.1 in 2025, then crashed by 147.32% to -$0.05 in 2026.
- Per Business Quant, the three most recent readings for OCS's EPS (Basic) are -$0.05 (Q1 2026), $0.1 (Q4 2025), and -$30.11 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 3.06 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 0.00 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 4.06 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 6.99 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 0.00 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.55 |
| 10 | Oculis Holding AG | 24.51 Bn | 24.21 Bn | - | -0.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.05 |
| Dec 31, 2025 | 0.10 |
| Sep 30, 2025 | -30.11 |
| Jun 30, 2025 | -0.05 |
| Mar 31, 2025 | -0.06 |
| Dec 31, 2024 | -0.07 |
| Sep 30, 2024 | -46.98 |
| Jun 30, 2024 | -0.05 |
| Mar 31, 2024 | -0.04 |
| Dec 31, 2023 | -0.34 |
| Sep 30, 2023 | -0.05 |
| Jun 30, 2023 | -0.03 |
| Dec 31, 2022 | -2.36 |